Pulmatrix, Inc. Files 8-K on Asset Acquisition/Disposition
Ticker: PULM · Form: 8-K · Filed: May 15, 2025 · CIK: 1574235
Sentiment: neutral
Topics: acquisition, disposition, corporate-event
Related Tickers: PULM
TL;DR
Pulmatrix (PULM) filed an 8-K for asset deal completion. Big moves ahead?
AI Summary
Pulmatrix, Inc. filed an 8-K on May 15, 2025, reporting the completion of an acquisition or disposition of assets. The filing also includes financial statements and exhibits related to this event. Pulmatrix, Inc. was formerly known as Ruthigen, Inc. and changed its name on April 11, 2013.
Why It Matters
This filing indicates a significant corporate event for Pulmatrix, Inc., likely involving the acquisition or sale of assets, which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Filings related to acquisitions or dispositions of assets can introduce significant changes to a company's structure and future prospects, warranting a medium risk assessment.
Key Players & Entities
- Pulmatrix, Inc. (company) — Registrant
- Ruthigen, Inc. (company) — Former company name
- May 15, 2025 (date) — Date of report
- April 11, 2013 (date) — Date of name change
FAQ
What specific assets were acquired or disposed of by Pulmatrix, Inc.?
The filing does not specify the exact assets involved in the acquisition or disposition.
What was the financial impact of this transaction on Pulmatrix, Inc.?
The filing mentions financial statements and exhibits are included, but does not detail the financial impact of the transaction.
When did Pulmatrix, Inc. officially change its name from Ruthigen, Inc.?
Pulmatrix, Inc. officially changed its name from Ruthigen, Inc. on April 11, 2013.
What is the primary business of Pulmatrix, Inc.?
Pulmatrix, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
What is the principal executive office address for Pulmatrix, Inc.?
The principal executive offices are located at 945 Concord Street, Suite 1217, Framingham, MA 01701.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Pulmatrix, Inc. (PULM).